Literature DB >> 10463752

Coral grafting supplemented with bone marrow.

S Louisia1, M Stromboni, A Meunier, L Sedel, H Petite.   

Abstract

Limited success in regenerating large bone defects has been achieved by bridging them with osteoconductive materials. These substitutes lack the osteogenic and osteoinductive properties of bone autograft. A direct approach would be to stimulate osteogenesis in these biomaterials by the addition of fresh bone-marrow cells (BMC). We therefore created osteoperiosteal gaps 2 cm wide in the ulna of adult rabbits and either bridged them with coral alone (CC), coral supplemented with BMC, or left them empty. Coral was chosen as a scaffold because of its good biocompatibility and resorbability. In osteoperiosteal gaps bridged with coral only, the coral was invaded chiefly by fibrous tissue. It was insufficient to produce union after two months. In defects filled with coral and BMC an increase in osteogenesis was observed and the bone surface area was significantly higher compared with defects filled with coral alone. Bony union occurred in six out of six defects filled with coral and BMC after two months. An increase in the resorption of coral was also observed, suggesting that resorbing cells or their progenitors were present in bone marrow and survived the grafting procedure. Our findings have shown that supplementation of coral with BMC increased both the resorption of material and osteogenesis in defects of a clinical significance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463752     DOI: 10.1302/0301-620x.81b4.9358

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  The incorporation of different sorts of cancellous bone graft and the reaction of the host bone. A histomorphometric study in sheep.

Authors:  P Leniz; P Ripalda; F Forriol
Journal:  Int Orthop       Date:  2003-05-15       Impact factor: 3.075

2.  EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Authors:  Yiyan Qiu; Yang Chen; Tenghui Zeng; Weizhuang Guo; Wenyu Zhou; Xinjian Yang
Journal:  Mol Biol Rep       Date:  2016-01-16       Impact factor: 2.316

3.  Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential.

Authors:  Hao Ding; You-Shui Gao; Yang Wang; Chen Hu; Yuan Sun; Changqing Zhang
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

4.  Testing bone substitutes in a small animal model of revision arthroplasty.

Authors:  S A Clarke; R A Brooks; N Rushton
Journal:  J Mater Sci Mater Med       Date:  2002-09       Impact factor: 3.896

5.  Bone Substitute Effect on Vascularization and Bone Remodeling after Application of phVEGF165 Transfected BMSC.

Authors:  Florian Geiger; Mirjam Beverungen; Helga Lorenz; Julia Wieland; Michael Fehr; Philip Kasten
Journal:  J Funct Biomater       Date:  2012-04-19

6.  No Detectable Alteration of Inorganic Allogeneic Bone Matrix Colonizing Mesenchymal Cells: A Step Towards Personalized Bone Grafts.

Authors:  Roger Erivan; Nicolas Samper; Guillaume Villatte; Stéphane Boisgard; Stéphane Descamps; Marc Berger
Journal:  J Bone Metab       Date:  2021-05-31

7.  Dimethyloxaloylglycine improves angiogenic activity of bone marrow stromal cells in the tissue-engineered bone.

Authors:  Hao Ding; Song Chen; Wen-Qi Song; You-Shui Gao; Jun-Jie Guan; Yang Wang; Yuan Sun; Chang-Qing Zhang
Journal:  Int J Biol Sci       Date:  2014-06-27       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.